Skip to main content

Global Tinea Corporis Market Size is expected to rise steadily at a CAGR of 7.2% during forecast period of 2018-2023

Tinea corporis is contagious infection which can spread from one person to other hence it is important not to share towel, flannels, bathmats with another person. Tinea corporis is a fungal infection that is caused by tinea rubrum, trichophyton mentagrophytes and epidermophyton floccosum fungi.
This fungal infection mainly occurs in humid climatic condition. It is also known as ringworm infection. Tinea corporis infection occurs mostly on arms, legs or can also occur on different parts of body. The global Tinea Corporis Market Size is expected to see the growth in upcoming year due to entry of new drug product in market for treatment. Many key players in market are engaged in development of new drug product for tinea corporis treatment.
Global Tinea Corporis Market Size is expected to rise steadily at a CAGR of 7.2% during forecast period of 2018-2023.
Market Segmentation:
Global Tinea Corporis Market Size is segmented into drug type, diagnosis, treatment and end-users. Tinea Corporis Market Size on basis of drug types is segmented into antifungals, steroids and anti-infective combinations.
Global Tinea Corporis Market Size by Drug Type
  • Antifungals
  • Steroids
  • Anti-Infective Combinations
Global Tinea Corporis Market Size, by Diagnosis
  • Physical Exam

  • Imaging Tests
    Wood lamp (black light) examination
    Microscopy using potassium hydroxide (KOH)
    Fungal culture
    Skin biopsy
    Others
Global Tinea Corporis Market Size, by Treatment
  • Antifungal shampoos
  • Antifungal creams
  • Drugs
  • Others
Global Tinea Corporis Market Size, by End-Users
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Dermatology hospitals
  • Others
Top Industry Key players:
Some of the key players in the global Tinea Corporis Market Size are –
  • Teva Pharmaceuticals Inc.
  • Glenmark Pharmaceuticals Inc
  • NorthStar Rx LLC
  • Aurobindo Pharma Limited
  • Camber Pharmaceuticals Inc.
  • AvKare Inc.
  • Novartis AG
  • Sebela Pharmaceuticals Inc.
  • Bayer AG
  • Blueberry Therapeutics Ltd
  • Perrigo Company
  • Taro Pharmaceuticals. Inc.
  • Breckenridge Pharmaceutical Inc.
LIST OF TABLES
Table 1 Global Tinea Corporis Market Size Synopsis, 2018–2023
Table 2 Global Tinea Corporis Market Size Estimates and Forecast, 2018–2023 (USD Million)
Table 3 Global Tinea Corporis Market Size, By Region, 2018–2023 (USD Million)
Table 4 Global Tinea Corporis Market Size, By Drug Type, 2018–2023 (USD Million)
Table 5 Global Tinea Corporis Market Size, By Diagnosis, 2018–2023 (USD Million)
Table 6 Global Tinea Corporis Market Size, By Treatment, 2018–2023 (USD Million)
Table 7 Global Tinea Corporis Market Size, By End-Users, 2018–2023 (USD Million0
…Continues.
Browse Complete Premium Research Report Enabled with TOC at https://www.marketresearchfuture.com/reports/tinea-corporis-market-6838
Regional Market Summary
Geographically, the America holds the highest market share for Tinea Corporis Market Size and the reason being many market players are engaged in development of new drug product innovation, and as this infection is more prone to humid climatic condition there is an increasing prevalence of fungal infection in this region. Whereas increasing awareness of fungal disease and rising healthcare expenditure by the government are some of the factors responsible for growth of market in this region
Europe is expected to be the second largest market in the globe owing to the increasing aging population, increasing prevalence of fungal infection, focus on aesthetic appearance, increasing research base. Whereas rise in susceptible immune compromised patient population is responsible for market growth in this region.
Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of fungal infection, changing lifestyle, increase in population, increasing healthcare expenditure by government are some of the factor responsible for market growth in this region.
Intended Audience
  • Manufacturers and Suppliers
  • Hospitals and Clinics
  • Laboratories and Associations
  • Research Institutes
  • Dermatology Clinics
About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

hyperpigmentation disorders treatment Overview

hyperpigmentation disorders treatment Analysis Hyperpigmentation disorder are harmless skin condition caused by darkened skin patches. Rising demand for outpatient dermabrasion procedures, increasing adoption of lasers and growing cosmetics expenditure are expected to drive the growth of the market. Additionally, rising R&D spending followed aggressive strategies by the key market players is generating awareness for the disease boosting the market to grow. The global hyperpigmentation disorders treatment Market was anticipated to held a market value of USD 3,915 million in the year 2017 and is expected to grow at a CAGR of 7.1% during the forecast period. Browse Complete Premium Research Report Enabled with Respective Tables and Figures at  https://www.marketresearchfuture.com/reports/hyperpigmentation-disorders-treatment-market-7462 Segmentation of The global h yperpigmentation disorders treatment market Segments  has been segmented based on treatment type, dise...
Post a Comment
Read more

Immunoassay Analyzers Market By Methods, Technologies, Clinical Review and Industry Outlook

  Immunoassay Analyzers Market  Research Report By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), Application (Infectious Diseases, Autoimmune Diseases, AIDS), End Users (Hospitals)- Global Forecast till 2023 Market Scenario Immunoassay analyzer is a device which measures the presence and concentration of proteins in analyte samples. These instruments are mostly used by pharmaceutical & biotechnological companies, laboratories, and research institutes. The global immunoassay analyzer market is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities. Furthermore, rapid development in diagnostic medical devices, increasing need for better drug treatment, and the increasing geriatric population had also fueled the market’s growth. On the other hand, high cost of instruments and poor reimburseme...
Post a Comment
Read more

Laser Therapy Market Top Company Profiles, Latest Technology, Global Size, Industry Trends

  Laser Therapy Market  Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) - Global Forecast from 2017 to 2023 Market Overview: Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global laser therapy market over the forecast period of 2017-2023. The expansion of the global laser therapy is the result of various market dynamics, out of which, the surging prevalence of diseases such as cataract and arthritis bears profound weightage. Laser therapy is the standard line of treatment in cases of cataract. Laser-based ophthalmology is highly preferred over other methods of treatment. YAG LASER, excimer LASER, femtosecond LASER, and others are the most commonly used lasers in ophthalmology. The widespread prevalence of cataract, as well as arthritis, promote the growth of the global laser therapy market. Expanding base of old...
Post a Comment
Read more